Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Chi Leung Chiang"'
Autor:
Keith Wan Hang Chiu, Chi Leung Chiang, Kenneth Sik Kwan Chan, Yuan Hui, Jingyun Ren, Xiaojuan Wei, Kwok Sing Ng, Ho Fun Victor Lee, Nam Hung Chia, Tan-To Cheung, Stephen Chan, Albert Chi-Yan Chan, Kwok Chai Kelvin Ng, Wai Kay Walter Seto, Pek-Lan Khong, Feng-Ming Kong
Publikováno v:
JHEP Reports, Vol 6, Iss 7, Pp 101099- (2024)
Background & Aims: Combined 18F-fluorodeoxyglucose (FDG) and 11C-acetate (dual-tracer) positron-emission tomography/computed tomography (PET/CT) is being increasingly performed for the management of hepatocellular carcinoma (HCC), although its role i
Externí odkaz:
https://doaj.org/article/fb1722525b5845439f13ab95b848b401
Publikováno v:
Cancers
Volume 15
Issue 4
Pages: 1105
Volume 15
Issue 4
Pages: 1105
This study aims to investigate the association of pre-treatment multi-phasic MR-based radiomics and dosimetric features with treatment response to a novel sequential trans-arterial chemoembolization (TACE) plus stereotactic body radiotherapy (SBRT) p
Publikováno v:
Hong Kong Journal of Radiology. 23:185-190
Autor:
Tan To Cheung, Chi-Leung Chiang, Kin Pan Au, Albert C. Y. Chan, Kenneth S. H. Chok, Chung Mau Lo
Publikováno v:
World J Clin Cases
BACKGROUND: Graft hepatocellular carcinoma (HCC) recurrence after liver transplant is more frequently encountered. Graft hepatectomy is technically challenging and is associated with high morbidity. Stereotactic body radiation therapy (SBRT) has been
Autor:
Chi-Leung Chiang, Keith Wan-Hang Chiu, Francis Ann-Shing Lee, Feng-Ming Spring Kong, Albert Chi-Yan Chan
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
Immunotherapy has achieved modest clinical activity in HCC patients. Propensity score matching analysis was conducted to compare the efficacy and safety of combined stereotactic SBRT-IO versus TACE in patients with locally advanced HCC in a tertiary
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e35-e36
PURPOSE/OBJECTIVE(S) We reported the first study of combined stereotactic body radiotherapy and immunotherapy (SBRT-IO) in unresectable hepatocellular carcinoma (uHCC) and found this combination was synergistic and safe. Based on these results, we co
Publikováno v:
Cancers
Volume 13
Issue 5
Cancers, Vol 13, Iss 931, p 931 (2021)
Volume 13
Issue 5
Cancers, Vol 13, Iss 931, p 931 (2021)
Simple Summary There is a growing body of literature demonstrating high cancer drug costs relative to the benefits provided to patients treated on a large scale. We examined the cost-effectiveness of atezolizumab–bevacizumab for the first-line trea
Autor:
Connie H. M. Ho, Frank Cs. Wong, Kelvin K. K. Ng, Victor Lee, Siu-Ho Chok, W.C. Dai, Cynthia S Y Yeung, Chi-Leung Chiang, To-Wai Leung, Albert Cy Chan, Tan To Cheung, T Wong, Mai-Yee Luk, Chung Mau Lo, Ann-Shing Lee
Publikováno v:
Surgical Oncology. 28:228-235
Background This study compared outcomes of nonresectable hepatocellular carcinoma (HCC) who had transarterial chemoembolization (TACE) vs. stereotactic body radiation therapy (SBRT) after TACE (TACE + SBRT). Methods This was a retrospective study of
Publikováno v:
Chinese clinical oncology. 10(1)
Primary liver cancer includes hepatocellular carcinoma (HCC, 75-85%) and intrahepatic cholangiocarcinoma (10-15%). The vast majority of patients with primary HCC are not candidates for surgical treatment. Surgical resection, liver transplantation and
Autor:
Venus W Y Lee, Cynthia S Y Yeung, Kam Sze Tsang, Natalie S. M. Wong, Connie H. M. Ho, S. K. Ha, Mark ka heng Chan, Francis A. S. Lee, Chi-Leung Chiang, B. Wang
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Scientific Reports
Scientific Reports
This study aims at evaluating the symptom response, response duration, and toxicity of single dose palliative liver radiotherapy (RT) for symptomatic HCC patients. We reviewed unresectable HCC patients treated with palliative RT in our institution. E